A Study in Prevention of Re-emergence of Depression Symptoms
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2875358 in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2090314 in Patients With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2801653 in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
- Status
- COMPLETED
- Phase
- NA
The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone
- Status
- TERMINATED
- Phase
- PHASE2
Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effect of LY2216684 on Lorazepam
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2216684 and Digoxin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
- Status
- COMPLETED
- Phase
- PHASE1